James P. Dellureficio
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Regulation of Appetite and Obesity, Biochemical Analysis and Sensing Techniques, melanin and skin pigmentation, Pain Mechanisms and Treatments, Cannabis and Cannabinoid Research
Most-Cited Works
- → Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain(2014)41 cited
- → Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist(2010)23 cited
- → Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity(2010)21 cited
- → Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity(2010)14 cited
- → Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4′-piperidine] based melanocortin subtype-4 receptor agonists(2010)12 cited